Page 62 - Formulation News Today

Dublin, Nov. 29, 2021 (GLOBE NEWSWIRE) -- The "U.S. Pharmaceutical Isolators Market Size, Share & Trends Analysis Report and Segment Forecasts, 2020...

The dry lysine or L-lysine supply crunch is expected to last into Q2 2022, says a US academic.

Singapore plant-based meat and seafood manufacturer Growthwell Foods has launched its latest consumer brand HAPPIEE!, which will be produced at a newly established innovation, R&D and manufacturing centre.

Sixty per cent of packaged non-alcoholic beverages (NABs) sold on the Singapore market contain high amounts of sugar and would be assigned under Grade C or D in the soon-to-be-implemented Nutri-Grade system.

Brands across personal care are developing waterless products to meet the demand of eco-focused consumers, but in formulation and manufacturing they come with their own safety and contaminations concerns.

Altasciences is an integrated drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services.

A meta-analysis of 13 clinical trials on more than 500,000 COVID-19 patients revealed no significant association between vitamin D supplementation and improved clinical outcomes based on current evidence.

The shortage of dry lysine or L-lysine is expected to last into Q2 2022, says a US academic.

AstraZeneca has built a new R&D facility - The Discovery Centre (DISC) - in Cambridge in the UK.

An anti-diabetic health functional food containing banaba leaf, bitter melon, and peony root extracts is expected to hit the South Korean market next year.